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Abstract
 
Objectives
 
: Defects of the mitochondrial genome
(mtDNA) cause a series of rare, mainly neurological
disorders. In addition, they have been implicated in
more common forms of movement disorders, dementia
and the ageing process. In order to try to model
neuronal dysfunction associated with mitochondrial
disease, we have attempted to establish a series of
 
trans
 
mitochondrial mouse embryonic stem cells
harbouring pathogenic mtDNA mutations.
 
Materials and methods
 
:
 
Trans
 
mitochondrial embryonic
stem cell cybrids were generated by fusion of cyto-
plasts carrying a variety of mtDNA mutations, into
embryonic stem cells that had been pretreated with
rhodamine 6G, to prevent transmission of endogenous
mtDNA. Cybrids were differentiated into neurons
and assessed for efficiency of differentiation and
electrophysiological function.
 
Results
 
: Neuronal differentiation could occur, as
indicated by expression of neuronal markers. Different-
iation was impaired in embryonic stem cells carrying
mtDNA mutations that caused severe biochemical
deficiency. Electrophysiological tests showed evidence
of synaptic activity in differentiated neurons carrying
non-pathogenic mtDNA mutations or in those that
caused a mild defect of respiratory activity. Again,
however, neurons carrying mtDNA mutations that
resulted in severe biochemical deficiency had
marked reduction in post-synaptic events.
 
Conclusions
 
: Differentiated neurons carrying severely
pathogenic mtDNA defects can provide a useful
model for understanding how such mutations can
cause neuronal dysfunction.
 
Introduction
 
Mitochondria are essential organelles, critically involved
in the life and programmed death of the eukaryote cell.
One of their major functions, oxidative phosphorylation,
occurs at the inner mitochondrial membrane and is
mediated by the four enzyme complexes of the respiratory
chain, and a fifth enzyme complex, ATP synthetase. Four
of these five multi-subunit complexes contain subunits
encoded by the mitochondrial genome (mtDNA). Not
surprisingly, therefore, mtDNA mutations can often be
pathogenic and the associated disease can affect any organ
system of the body. Critically, however, neurological
symptoms are an almost invariant feature. These can be
mild, but are more usually severe and progressive, leading
to disability and death. Typical mtDNA syndromes are
rare (1), but mitochondrial dysfunction is implicated in
other more common neurodegenerative diseases, such as
Parkinson’s disease (2) and in the ageing process itself
(3,4). Exact mechanisms of damage to neurons in mtDNA
disease are unknown, and study of such processes at a
cellular level may lead to improved treatment and greater
understanding of the role of mtDNA mutations in neuro-
degenerative disease and ageing.
Obtaining fresh neuronal material from patients with
mtDNA disease is impossible because neurosurgery is not
a treatment for the disease; thus, a model system whereby
neuronal function can be assessed in cells carrying mutated
mtDNA could be very informative. One possible source
would be from transgenic mice carrying defective mtDNA
in neurons. To date, however, there have been difficulties in
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producing transgenic mice carrying profound pathogenic
mtDNA mutations (5) (R.N.L., personal observation), and
it has not been possible to completely recapitulate, in
mice, all the symptoms of any form of neuronal disorder
associated with mtDNA defects. Thus, we have focussed
on embryonic stem (ES) cell expertise to produce neurons
that can be studied in culture, derived from ES cells
carrying pathogenic mtDNA defects.
Development of 
 
trans
 
mitochondrial technology, where
enucleated somatic cells harbouring pathological mtDNA
mutations are fused with a cell line in which the endogenous
mtDNA has been chemically ablated (a 
 
ρ°
 
 cell line), has
enabled the study of consequences of mtDNA mutations
at the cellular level (6–8). However, conventional cybrids
using patient-derived platelets or fibroblasts tell us nothing
about the cellular pathophysiology of defined tissue types,
particularly about the neurological component of mtDNA
disease. We have now used this set of skills to produce a
series of murine ES cell lines harbouring defective mtDNA.
Sequence variants of the mitochondrial genome present
in mouse fibroblast cell line L929 were introduced into
mouse ES cells (ES-I and ES-VI). One ES cell line has
two mutations in different 
 
Mtnd
 
 genes, which severely
reduced (< 10%) residual complex I activity. Two others
were created with a mutation in 
 
Mtco1
 
 and a moderate
complex IV defect (~35% residual activity) (9). As control,
another ES cell line contains a polymorphic variant in
the 
 
Mttr 
 
gene encoding mt-tRNA
 
Arg
 
 (10). ES cell-derived
cybrids retained their pluripotency, and were able to
differentiate into neurons when deprived of leukaemia
inhibitory factor (LIF) and supplemented with retinoic
acid (11). The resulting neurons had small cell bodies and
long neurites and expressed typical markers of neuronal
and glial cells, while patch clamp analysis demonstrated
action and synaptic potentials. We report here that neuronal
differentiation was severely affected in the ES cell line
carrying the most profound defect. In addition, single cell
electrophysiological measurements were consistent with
compromised post-synaptic events in neurons from the
profoundly deficient cell line, although further analysis
is needed to confirm this observation.
 
Materials and methods
 
Cell culture conditions
 
Cells were cultured in a humidified incubator maintained
at 37 
 
°
 
C with 5% CO
 
2
 
. Mouse fibroblasts were grown in
Dulbecco’s modified Eagle’s medium (DMEM, Sigma,
St. Louis, MO, USA) and 10% foetal calf serum (FCS, Biosera,
Ringmer, UK), supplemented 2 m
 
m
 
 
 
l
 
-glutamine (Invitrogen,
Carlsbad, CA, USA). Mouse ES cells for fusions were grown
on mitotically inactivated SNL fibroblast (gift of Dr Allan
Bradley, Sanger Centre, Cambridge, UK) feeder layers in
DMEM and 10% FCS, supplemented with uridine (50 
 
μ
 
g/ml),
non-essential amino acids and 0.1 m
 
m
 
 2-mercaptoethanol.
The feeder layer cells contain a LIF expression construct
(12) and although express LIF abundantly (13), the medium
was further supplemented with mouse recombinant LIF
(1 ng/ml, Chemicon, Millipore (Chemicon) Watford, UK).
ES cells destined for differentiation were grown on a surface
treated with 0.1% (w/v) porcine skin gelatine (Sigma) in
Glasgow modified Eagle’s medium (Invitrogen) and 10% FCS,
supplemented with 1 m
 
m
 
 sodium pyruvate, 2 m
 
m
 
 
 
l
 
-glutamine,
non-essential amino acids, 0.1 m
 
m
 
 2-mercaptoethanol and
mouse recombinant LIF (1 ng/ml, Chemicon).
 
Parental cell lines
 
Mouse ES cells used in this study were ES-I (CC9.3.1)
and ES-VI (MPI-VI (14) a gift of Prof. Anne Voss, Walter
and Eliza Hall Institute, Melbourne, Australia). Mouse
fibroblasts carrying pathogenic mtDNA mutations were
derived from the mouse L929 cell line, which has fixed
several mutations over long-term culture. Nucleotides are
numbered according to the C57BL/6J mouse mtDNA
sequence (GenBank AY172335) (15). Clones with different
sequence variations were used as mitochondrial donor cell
lines: E9 with a 6589T>C (V421A) mutation in 
 
Mtco1
 
, one
of the three mtDNA encoded complex IV genes (9); C5
with two different mutations in mtDNA genes encoding
complex I subunits, a frameshift mutation, 13887Cins in
 
Mtnd6
 
 (9,16) and a point mutation 12273G>A in 
 
Mtnd5
 
.
The 
 
Mtnd5
 
 mutation was heteroplasmic (90% mutant); all
others were present in homoplasmic form. Donor cell line
for the polymorphic marker was mouse C57BL/6JC57,
which carried a variation (8As) in the length of a stretch
of As at a highly polymorphic site in the DHU loop of
mt-tRNA
 
Arg
 
 (15).
 
Creation of transmitochondrial cybrids
 
Generation of 
 
trans
 
mitochondrial ES cybrid cell lines was
performed, essentially as described in Sligh 
 
et al.
 
, with
slight modifications (17). To ablate mtDNA, ES cell lines
(~ 1 
 
×
 
 10
 
6
 
 ES-I or ES-VI) were pretreated for 3 days
with rhodamine 6G (R6G; 1 
 
μ
 
g/ml final concentration) in
DMEM containing uridine (50 
 
μ
 
g/ml), non-essential amino
acids and 0.1 m
 
m
 
 2-mercaptoethanol. Two hours prior to
fusion, medium was removed and replaced by identical
media lacking R6G. Cytoplast donor cell lines (~3 
 
×
 
 10
 
6
 
)
carrying different mtDNA mutations were incubated in
dishes in DMEM containing cytochalasin B (100 
 
μ
 
g/ml)
for 2 h, and then enucleated by centrifugation at 7000 
 
g
 
for 20 min at 37 
 
°
 
C in a Sorvall SLA-1500 (Thermo Fisher
Scientific, Loughborough, UK) rotor. R6G-treated cells and
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donor cytoplasts were harvested following trypsinization
and pelleted together at 150 
 
g
 
, then gently suspended in
0.5 ml of pre-warmed (37 
 
°
 
C) 50% PEG1500 in serum-free
DMEM. Cells were exposed to the PEG for 1 min, serum-
free DMEM (5 ml) was added and cells were pelleted at
100 
 
g
 
, suspended in DMEM containing uridine (50 
 
μ
 
g/ml)
and plated on a feeder monolayer. Next day the medium was
replaced with DMEM without uridine to select against
unfused recipient ES cells. After 6–9 days, clones were
picked and expanded for further analysis.
 
Presence of mtDNA mutations
 
Putative cybrids were screened for presence of the 6589T>C
and 12273G>A mutations by polymerase chain reaction–
restriction fragment length polymorphism (PCR-RFLP)
analysis. For 6589T>C, DNA was amplified using primers
CATGAGCAAAAGCCCACTTCGCCATCATATTCGT
AGGCG-3
 
′
 
 (forward) and 5
 
′
 
-GTGTTTCATGTGGGTGCGC
ATCTGG-3
 
′
 
 (reverse). This gave a 133-bp product, which
was digested with 
 
Cfo
 
I to give products of 115 and 18 bp
for the wild-type sequence, and 75, 40 and 18 bp for the
mutant sequence. For 12273G>A, primers 5
 
′
 
-ACTGCAG
CCCTACAAGCAATCCTCTATAACCGCCTC-3
 
′
 
 (forward)
and 5
 
′
 
-TTGTGCTGATTTTCCTGTAGCTGCGATTAAT
AGGCC-3
 
′
 
 (reverse) were used, giving a 182-bp PCR product.
This produced a 
 
Dde
 
I restriction site in the mutant sequence,
yielding products of 145 and 37 bp on digestion.
For 13887C ins, a 760-bp region of 
 
Mtnd6
 
 was PCR-
amplified using the primers 5
 
′
 
-CACACAAACATAAC
CACTTTAACA-3
 
′
 
 (forward) and 5
 
′
 
-GTAGGTCAATGA
ATGAGTGGTT-3
 
′
 
 (reverse) (17). Remaining free
nucleotides were removed and the PCR product used as a
template for primer extension using a primer with a
5
 
′
 
 D3 fluorescent conjugate (5
 
′
 
(D3)CGTATATCCAAAC
ACAACCAACAT-3
 
′
 
). Analysis of primer extension products
was carried out on a Beckman CEQ8000 Genetic Analysis
System (Beckman/Coulter, High Wycombe, UK). For the
9821Adel polymorphism, primer extension was used to
verify the length of a track of A residues starting at posi-
tion 9821 in 
 
Mttr
 
, as detailed in Bayona-Bafaluy 
 
et al.
 
(15). A 377- to 379-bp fragment containing this region was
amplified by PCR with the following primers: (i) forward
CTACTTCCACTACCATGAGC (positions 9672–9691);
(ii) reverse GTATGGAGCTTATGGAGTTGG (positions
10 028–10 048). The 
 
32
 
P-labeled primer used for primer
extension was Arg-PE, GGATTAGAATGAACAGAG
TAAATGGTAATTAGTTT (positions 9786–9820). Primer-
extended products generated were analysed using 8%
polyacrylamide/7 
 
m
 
 urea sequencing gels, dried and exposed
for autoradiography.
Cell lines harbouring a high level of the sequence
variations were selected for further studies.
 
Microsatellite marker analysis
 
A candidate informative marker, D6mit102, predicted to
discriminate cell lines used in this study, was identified from
the Jackson Laboratories informatics website (http://www.
informatics.jax.org). D6Mit102 amplified a 177-bp sequence
in MPI-VI ES cells, a 177- and 145-bp doublet in CC9.3.1 ES
cells, and the expected 125-bp sequence in the L929 fibro-
blasts. For D6Mit102 analysis, DNA from parental cell lines
and putative cybrids was PCR-amplified using the primers
5
 
′
 
-CCATGTGGATATCTTCCCTGG-3
 
′
 
 (forward) and 5
 
′
 
-
GTATACCCAGTTGTAAATCTTGTGTG-3
 
′
 
 (reverse).
 
Maintenance of pluripotency
 
Cybrids were cultured in the presence or absence of LIF for
9 days before extraction of RNA. Reverse transcription of
RNA (1 
 
μ
 
g) was carried out using the Superscript First-Strand
Synthesis System kit (Invitrogen) using random hexamers
as primers. Oct-4 and 
 
β
 
-actin were PCR-amplified from the
resulting cDNA using the primers 5
 
′
 
-GGCGTTCTCTTT
GGAAAGGTGTTC-3
 
′
 
 (OCT-4 forward) and 5
 
′
 
-CTCGA
ACCACATCCTTCTCT-3
 
′
 
 (OCT-4 reverse) and 5
 
′
 
-GGCC
CAGAGCAAGAGAGGTATCC-3
 
′
 
 (
 
β
 
-actin forward) 5
 
′
 
-
ACGCACGATTTCCCTCTCAGC-3
 
′
 
 (
 
β
 
-actin reverse).
 
Respiratory chain enzymology
 
Respiratory chain enzymes were measured in hypotonically
treated mitochondrial fractions prepared from the undif-
ferentiated cybrids and the parental ES cells as described
(18,19) All assays were performed in duplicate.
 
Production of cybrid-derived neurons
 
The parental ES and the cybrid cell lines were differentiated
into neurons using the 4–/4+ protocol of Bain 
 
et al.
 
 (11).
Briefly, cells were allowed to form embryoid bodies in
suspension in non-tissue culture plastic, 10 cm diameter
dishes, by deprivation of LIF for the remainder of different-
iation and addition of 
 
all-trans
 
 retinoic acid (1 
 
×
 
 10
 
–6
 
 
 
m
 
,
Sigma) for the last 4 days of the 8 days in suspension. A
single cell suspension was then derived from the embryoid
bodies by trypsinization. Cells (1 
 
×
 
 106 per coverslip) were
plated onto glass coverslips (22 mm diameter) coated with
poly-d-lysine (0.001%, Sigma) and laminin (0.005%,
Sigma), and allowed to differentiate in the presence of
fibroblast growth factor (bFGF, 10 ng/ml, Chemicon) for
2 days in a 4 : 1 mixture of Neurobasal medium (Invitrogen)
supplemented with B27 (Invitrogen) and DMEM : F12
(1 : 1) (Invitrogen) supplemented with modified N2 (20).
The medium was then replaced with 4 : 1 medium without
bFGF, and then half the medium was replaced every 2 days.
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Immunocytochemistry
Differentiated neurons on the coverslips were fixed by
treatment with 4% paraformaldehyde for 10 min. Cells
were then washed in phosphate-buffered saline containing
0.1% triton X-100 (PBST), and blocked for 1 h with 4%
BSA in PBST. Primary antibodies in 4% BSA in PBST
(β-tubulin III; glial fibrillary acidic protein, GFAP) or 5%
normal goat serum in PBST (GABA; NeuN) were applied
for 1–2 h at room temperature or overnight at 4 °C. Cells
were stained with antibodies to β-tubulin III at dilution of
1 : 400 (SDL3D10, Sigma); GFAP at 1 : 400 (MAB360,
Chemicon), GABA at 1 : 200 (A2052, Sigma); NeuN at
1 : 200 (MAB377; Chemicon). Cells were washed three times
with PBST. Fluorescently labelled secondary antibodies
(rabbit anti-mouse labelled with fluorescein isothiocyanate
(Dako, Glostrup, Denmark), or swine anti-rabbit labelled
with TRITC (Serotec, Serotec Ltd, Kidlington, UK), 1 : 100
dilution in 4% BSA in PBST; 1 : 200 goat anti-rabbit labelled
with fluorescein isothiocyanate or 1 : 200 goat anti-mouse
IgG1 labelled with rhodamine in 5% normal goat serum
in PBST for GABA and NeuN) were applied for 1 h, then
the cells were washed with PBST, PBS, and then water, and
mounted on microscope slides with Vectashield mounting
medium for fluorescence with 4′,6-diamidino-2-phenylindole
(DAPI; Vector Laboratories, Burlingame, CA, USA). Cells
were examined by fluorescence microscopy for β-tubulin III
and GFAP staining using a Zeiss Axioplan 2 imaging
system with Axiovision software. GABA and NeuN staining
was imaged using an Axioskop FS microscope fitted with a
spinning disc confocal head (Visitech International,
Sunderland, UK) and photographed using Visitech software.
Cells were counted post-hoc from the confocal images.
Ability of the cells to differentiate into neurons was
estimated on day 13 of differentiation by comparing number
of cells staining positively with antibodies directed against
neuronal marker β-tubulin III, with number of nuclei
stained with DAPI (Fig. 3). The numbers of β-tubulin III-
positive cells and DAPI-positive nuclei were counted in
10 randomly selected visual fields, and percentage of
β-tubulin III-positive cells relative to DAPI-positive nuclei
was calculated. This was performed for two independent
differentiation experiments (that is, results represent
2 × 10 fields at ×100 magnification) for all except CY1-I
in which efficiency of differentiation into neurons was
quantified only once (1 × 10 fields).
Electrophysiology
Cultures were transferred into a recording chamber, which
was mounted on an upright Zeiss Axioskop FS micro-
scope fitted with Luigs & Neumann micromanipulators.
There, they were bathed in a continuously flowing stream
(1–3 ml/min) of artificial cerebrospinal fluid (in mm:
NaCl, 125; NaHCO3, 26; glucose, 10; KCl, 3.5; CaCl2,
1.2; , 1.26; MgSO4, 1). Whole cell patch clamp
recordings were made using 5–7 mΩ pipettes (borosilicate
glass; Harvard Apparatus, Holliston, MA, USA). The
pipette solution contained (in mm) K-methylsulphate,
125; K-HEPES, 10; Mg-ATP, 2.5; NaCl, 6; Na-GTP, 0.3
(corrected to pH 7.3–7.35 using KOH; 280 mOsm). Data
were collected using Axopatch 1D amplifiers (Molecular
Devices Ltd, Wokingham, UK), filtered at 3 kHz, digitized
at 5 kHz (AD board) and recorded on an Apple Macintosh
computer using Axograph software. All recordings were
made at room temperature.
Glutamate application
Glutamate (1 mm in artificial cerebrospinal fluid) was
applied directly from patch pipettes (5–7 megaohms when
filled with K-methylsulphate electrode filling solution (see
below)) using a Picospritzer II pressure application system
(Parker Instruments, Fairfield, NJ, USA, 10 ms pulses; pressure
= 20 psi). Timing of pressure applications was controlled using
the Master 8 pulse stimulator (AMPI, Jeruselam, Israel). The
pipette tip was in the order of 15–30 μm from the cells,
and, unless the pipette was broken, we never detected
any movement artefact during glutamate applications,
indicating that this means of stimulating cells was relatively
atraumatic. We discarded data if the pipette was broken.
We calculated that the average bolus for a 10-ms pressure
application through these pipettes was around 1.6 μl.
Results
Transfer of mtDNA variants to ES cells
Cybrid clones were generated and analysed for presence
of the mtDNA variants as detailed in the Materials and
methods section and nomenclature is provided in Table 1.
RFLP analysis confirmed that clones CY2-I and CY2-VI
contained homoplasmic levels of the 6589T>C mutation
in Mtco1, while 12267G>A was present at 90% hetero-
plasmy in CY3-I (Fig. 1a,b). Primer extension assays
confirmed homoplasmic levels of the 13887Cins and
9821Adel in CY3-I and CY1-I, respectively (Fig. 1b,c).
Absence of fibroblast nuclear background in the cybrids
was assessed by analysis of the informative polymorphic
microsatellite marker D6mit102 (Fig. 1d).
PCR amplification of the ES cell parental DNA gave
fragments of 177 bp and 145 bp for ES-I, or 177 bp alone
from the ES-VI. E9 and C5 fibroblasts gave a product of
125 bp. There was no evidence of a 125-bp fragment
attributable to either the E9 or C5 fibroblast DNA in the
cybrids containing the Mtco1 mutation, CY2-I and
NaH PO2 4−
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CY2-VI, or those containing the Mtnd mutations, CY3-I.
Thus, nuclear DNA microsatellite markers present in the
cybrids corresponded to those present in ES cell parent
only, confirming that cell lines contained only the ES
cell parent nucleus, and were indeed cybrids, not hybrids.
Similar confirmation was also noted with the CY1-I
cybrid (data not shown).
Pluripotency of the ES parental cells and the cybrids
was assessed by monitoring expression of OCT-4, a
transcription factor that is expressed in undifferentiated
pluripotent cells and not in differentiated cells. OCT-4
expression was present when both the ES parental cells
and the cybrids remained undifferentiated in the presence
of LIF. When the cultures were deprived of LIF for 9 days,
OCT-4 expression was absent (Fig. 1e). These results are
consistent with the cybrids retaining pluripotency follow-
ing the fusion, selection and expansion process.
Activities of respiratory chain components in 
transmitochondrial ES cell lines were similarly affected to 
the donor cell lines
Biochemical consequences of the mtDNA variations were
assessed by measuring activities of the respiratory chain
enzymes (complexes I, II, III, and IV) in the ES parental
cells and the cybrids (Table 2). Activities of respiratory
chain enzymes were determined spectrophotometrically
and expressed relative to activity of the mitochondrial
matrix marker enzyme citrate synthase (CS ratios), as
percentages of the CS ratios in the ES parental cell line.
Citrate synthase activities were similar in all cell lines,
ranging from 429 to 542 nmol min/mg. Presence of the
9821A(del) polymorphism in Mttr in clone CY1-I results
in reduction of complexes I, II, III and IV, with activities of
56–74% of the parental ES cell line, ES-I. These reductions
are not substantial, and reflect the subtle phenotype reported
by Moreno-Loshuertos et al. (10). Clone CY3-I with the
two mutations in different Mtnd genes (13887Cins in
Mtnd6 and 12273 G>A in Mtnd5) has a severe complex
I defect (7% of ES-I activity) as previously reported in
fibroblasts with the homoplasmic Mtnd6 mutation (17).
The two cybrid clones with the 6589T>C mutation in
Mtco1 (CY2-I MILD and CY2-VI MILD) both have
residual complex IV activity of 37% of their parental
ES cell lines, ES-I and ES-VI, respectively, consistent
with activity reported for the parental L929 mutants (9).
Thus, the cybrid cell lines harbour mtDNA variations,
which result in a spectrum of biochemical phenotypes
(Tables 1 and 2) ranging from severe (Mtnd5/nd6
mutations), to moderate (Mtco1 mutations), to insignificant
(Mttr polymorphism).
All differentiated transmitochondrial cell lines expressed 
neuronal markers
Cybrids with typical neuronal appearance were apparent
within 12 h of plating on to the poly-d-lysine/laminin-coated
coverslips. Where neuronal cell bodies were clustered
together, numerous processes extended from and between
the clusters, suggesting that some synaptic connections
may have existed. With extended culture, more and longer
neurites were apparent, with more connections, between
clusters as well as between distinguishable individual
cell bodies.
The differentiated cultures of all four main types
(parental, polymorphism, complex I, complex IV) contained
cells that not only morphologically appeared to be neurons,
but also stained positively with β-tubulin III from the
perinuclear region in the cell body to the ends of all
neuronal processes (Fig. 2); β-tubulin III is only expressed
in neurons. These cultures also contained astrocytes, as
Table 1. Phenotype and mtDNA genotype of transmitochondrial cybrid cell lines used in this study
Cybrid cell line Nuclear background mtDNA mutation (gene) Respiratory defect
Cy1-I ES-I 9821A del Mttr Non-pathogenic
Cy2-I ES-I 6589T>C Mtco1 Mild
Cy2-VI ES-VI 6589T>C Mtco1 Mild
Cy3-I ES-I 13887C ins Mtnd6 Severe
12273G>A Mtnd5
Table 2. Respiratory chain enzyme activities in undifferentiated cybrids.
The activities are expressed relative to the mitochondrial matrix enzyme
citrate synthase (CS ratio), as percentages of the CS ratio in the parental
embryonic stem (ES) cell line
Ratio enzymatic activity Transmitochondrial cybrid % ratio of 
parental ES cell line
CY1-I CY2-I CY2-VI CY3-I
Complex I/CS 74 71 97 7
Complex II/CS 56 64 132 83
Complex III/CS 83 114 143 89
Complex IV/CS 57 37 37 57
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Figure 1. Production of transmitocondrial murine embryonic stem (ES) cell cybrids. (a) Transfer of mtDNA carrying a mild mutation in Mtco1
to pluripotent ES-I and ES-VI ES cell lines. A 133-bp amplicon spanning nt6589 was generated from the indicated ES parental cells (ES-I,
lanes 2 and 4; ES-VI, lanes 9 and 11), 6589T>C fibroblasts (E9, lanes 3, 5, 10 and 12) and ES cybrids (CY2-I, lanes 7 and 14) as detailed in
the Materials and methods and subjected to digestion with Cfo1. Cleavage generated a 115- and 18-bp fragment for the wild-type amplicon
(lanes 2, 9), with further digestion of the 115-bp fragment to 75 and 40 bp indicating the 6589T>C mutation (lanes 3, 7, 10 and 14). Uncut amplicon
(lanes 4, 5, 11 and 12), negative control (lanes 6 and 13) and molecular weight markers (lanes 1, 8) are also shown. (b) Transfer of mutations in
Mtnd5 and Mtnd6 to ES-I. A 182-bp amplicon spanning nt12273 was generated from ES parental cells (ES-I, lanes 2 and 4), 12273G>A
fibroblasts (C5, lanes 3 and 5) and ES cell cybrids (CY3-I, lane 6) as detailed in the Materials and methods and subjected to cleavage with Dde1. 
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demonstrated by the astrocytic marker, GFAP (Fig. 2f,g).
Many, perhaps all, of the neurons (defined by β-tubulin III
expression) also expressed NeuN, a nuclear marker of
mature neurons (Fig. 3, red) (T.K.S-S., personal obser-
vation). In addition, a proportion of the neurons also
expressed GABA, a neurotransmitter (Fig. 3, green), in
the cell bodies and along the neurites. However, only
~15–20% of total number of neurons (assessed by NeuN
expression) expressed GABA (ES-I 15.2 ± 10.9%; Cy1-I
16.1 ± 2.7%; Cy2-I 21.5 ± 11.0%; Cy3-I, 15.9 ± 4.2%,
averages from five independent differentiations and 10
counted fields for each cell type). Thus, there were likely
to be neurons in these cultures expressing other neuro-
transmitters. As the percentage of GABA-positive neurons
did not vary significantly between cultures, irrespective of
mutation, respiratory chain dysfunction did not appear to
affect which type of neurotransmitter was expressed by
the differentiated neurons. Clearly, all transmitochondrial
cell lines were able to differentiate into neurons in culture,
as assessed by morphology and expression of neuronal
markers.
Figure 2. Transmitochondrial embryonic stem
(ES) cells can be differentiated into neurons
and astrocytes. Parental ES cell lines (a and f,
ES-I; d, ES-VI) and cybrids (b and g, CY3-I
SEVERE; c, CY2-I MILD; e, CY2-VI MILD)
were differentiated and fixed on Day 13 for
immunohistochemical analysis with the pan-
neuronal anti-β-tubulin III antibody (a–g, green)
and astrocytic marker anti-GFAP (F and G, red)
as detailed in the Materials and methods. Nuclei
are visualized by DAPI staining (blue). The sizing
bar represents 20 μm.
Products carrying the mutation were cleaved to generate fragments of 145 and 37 bp (lanes 3 and 6). Uncut amplicon (lanes 4 and 5) and molecular
weight ladder (lane 1) are shown. For analysis of mtDNA carrying the 13887C insertion, primer extension was performed as detailed in the Materials
and methods. The panels show the length of extension corresponding to the normal mtDNA sequence (ES-I, ~30 bp) or to the mtDNA carrying the
single base insertion (CY3-I, ~31 bp). The fluorescence signal due to the 5′ D3 fluorescent conjugate is indicated. The conjugated standard (13 nt) is
also shown. (c) Transfer of the Mttr polymorphism to ES-I. Primer extension was used to determine the length of the polyA tract around nt9821 in
the mtDNA of various cell lines as detailed in the Materials and methods. Parental ES cells (ES-I, lane 3), donor fibroblasts (C57BL/6J, lane 2) and
cybrids (CY1-I, lane 1) are shown, as well as the 10A extension found in L929 fibroblasts (lane 4). Radiolabelled oligonucleotide is also shown (oli).
(d) Microsatellite markers confirm production of transmitochondrial cybrids. Amplicons spanning the informative marker D6mit102 were prepared
from ES parental cells (ES-I, lane 2; ES-VI, lane 3), fibroblast donors (E9, lane 4; C5, lane 7) and cybrids (CY2-I, lane 5; CY2-VI, lane 6; CY3-I,
lane 8). Molecular weight markers are shown in lane 1. (e) Oct-4 expression in parental and cybrid ES cells is dependent on leukaemia inhibitory
factor (LIF). Cell lines (ES parental lanes 2, 3; cybrids lanes 4–6) were grown in the presence (+) or absence (–) of LIF for 9 days before RNA was
isolated and reverse transcribed. Amplicons from the transcripts encoding β-actin or Oct-4 were generated as described in the Materials and methods.
Molecular weight standards are given (lane 1).
Figure 3. GABAergic neurons are present in subpopulations of
differentiated transmitochondrial cells. Following 15–16 days of
differentiation, cells were analysed for the expression of an early neuronal
marker (NeuN, red) and the presence of GABA (green) as detailed in the
Materials and methods. Co-expression is shown in the image as yellow. The
size marker represents 10 μm. (a) Differentiated parental ES-I; (b) CY1-I
carrying the polymorphic marker; (c) CY2-I carrying the mild respiratory
defect; (d) CY3-I carrying the severe respiratory defect.
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Cybrids with the greatest deficiency in respiration were 
the most affected in differentiation
Expression of β-tubulin III was used to indicate different-
iation into neurons. On day 13 of differentiation (day 5
post-plating), the number of cells staining positively for
β-tubulin III was counted and compared with the number
of nuclei present as visualized by DAPI staining (Fig. 4).
The percentage of neurons generated from the cells with
the Mttr polymorphism (CY1-I; 73%) was not significantly
different from the number of neurons generated from
parental cells (ES-I, 53%; Mann–Whitney, P = 0.103).
For both ES cell cybrids carrying the mild Mtco1 mutation,
the percentage of neurons generated (CY2-I, 69.1%;
CY2-VI, 70.4%) was again comparable to the parental
efficiency (ES-I, 53%, P = 0.095; ES-VI, 63.9%, P = 0.393,
respectively). Any increases in efficiency when compared
to parental cells were not significant. However, for the ES
cell cybrid CY3-I, carrying two mtDNA mutations affecting
complex I activity, only 21% of cells showed neuronal
development, compared with 53% in the parental ES cell
line ES-I (P = 0.0013). Thus, a major effect of the severe
respiratory chain defect was to reduce efficiency of
neuronal generation.
Neurons with the highest level of respiratory deficiency 
were markedly affected in synaptic activity
Patch clamp recordings were made from 135 cells on
50 culture plates representing all cell lines, at a range of
developmental stages between post-plating days 6 and 20
(Table 3). All cells had extremely high input resistance
(101 cells from 34 cultures analysed; Table 3). Given that
this generally was within an order of magnitude of the
typical seal resistance (5–10 mΩ), the artefact leak
current around the tip of the pipette constituted a large
fraction of total current at rest. Therefore, this difficult-to-
measure artefact precluded true estimation of the resting
membrane potential. However, firing properties of the
cells could be assessed by injecting a small hyperpolarizing
current to lower the resting membrane potential to –70 mV.
A range of firing responses was subsequently generated in
all cell lines at several developmental stages by injecting
positive suprathreshold current pulses into the soma
(Fig. 5a). The various firing patterns indicate that all
cultures included heterogeneous neuronal populations that
expressed a range of excitable conductances.
Connectivity within the networks was assessed by
recording spontaneous post-synaptic currents, holding
the cells at –70 mV in voltage clamp mode (Table 3). In
control cell lines and the cell lines containing mild
mitochondrial deficits, synaptic events could be recorded
in cultures only 6–7 days post-plating, although most
Figure 4. Severe respiratory deficiency affects neuronal differentiation
of murine embryonic stem (ES) cells. Cell lines were induced to dif-
ferentiate as described in the Materials and methods. On day 13, cells
were subjected to immunohistochemistry with anti-β-tubulin III (late pan-
neuronal marker). Fields (n = 10) were selected and the percentage of
cells differentiating into neurons was calculated with reference to the
total number of DAPI-staining nuclei in the field. This was done for two
independent differentiation experiments, i.e. the results represent 2 × 10
fields at ×100 magnification, for all except for CY1-I, in which efficiency of
differentiation into neurons was quantified only once (1 × 10 fields). ES-I
and ES-VI, parental murine ES cells; CY1-I, polymorphism; CY3-I,
severe respiratory defect; CY2-I and CY2-VI, mild respiratory defect.
Table 3. Electrophysiological recordings of differentiated parental embryonic stem (ES) cells and transmitochondrial ES cell cybrids
ES-I ES-VI Cy1-I Cy2-I Cy2-VI Cy3-I
No. of cells 25 13 12 8 18 25
No. of cultures 9 3 5 3 4 10
Age range 6 to 11 6 to 20 8 to 19 7 to 10 6 to 20 8 to 17
(Post-plating day)
Input resistance (mΩ)
Average 1.6 1.9 2.0 1.9 1.9 3.8
Standard deviation 1.5 1.4 1.9 0.9 2.3 3.6
Range (0.2–5.5) (0.3–4.0) (0.7–5.4) (0.8–3.0) (0.5–10.0) (0.9–17.2)
Synaptic connectivity (% cultures) 67 33 60 33 50 20
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cultures of this age were synaptically quiescent. In the
various control lines, most cultures showed evidence of
synaptic events after this stage (Table 3; Fig. 5b). Even if
individual cells did not show evidence of synaptic
connectivity, other cells in the same culture could then
be recorded, which clearly did receive synaptic inputs.
Thus, cultures of control cell lines and those with mild
mitochondrial defects routinely formed synaptically
interconnected neural networks.
In contrast, synaptic events in the cell lines expressing
severe mitochondrial mutation were rarely evidenced.
Out of 25 recordings from 10 different culture plates,
post-synaptic currents were recorded in just four cells
(two different cultures: one at post-plating day 8, and one
at post-plating day 15). Recordings from five out of six
cells at a relatively late developmental stage (post-plating
days 15–17) were completely quiescent synaptically. It
was clear, however, that the synaptic quiescence was not
due to a lack of responsiveness in the recorded neuron
since large depolarizing currents could be induced in
these cells by brief applications of 1 mm glutamate, even
driving them to firing (Fig. 5c). Absence of synaptic
Figure 5. All cell lines produce neurons with a range of firing patterns. (a) Example of adapting and non-adapting firing patterns are shown in
response to square pulses of current injected somatically. Individual cells only ever show one firing pattern, but examples of each type are found in
all cell lines. (b) Typical examples of spontaneous synaptic currents recorded in cultured neurons held at –70 mV. In the control and mild mitochondrial
mutant cell lines, synaptic currents are routinely recorded in all cells after about the 2nd week after plating (parental recording is at 6 days post-plating;
mild mutant recording – 13 days post-plating). In contrast, recordings from the severe mutant cell line are routinely devoid of synaptic currents at all
ages recorded (example is at post-plating 17). (c) Glutamate applications. Panel (c-i) shows a differential interference micrograph of the experimental
arrangement with the puff electrode located 10–20 μm from the patched cell. Panels (c-ii) and (c-iii) show responses to exogenously applied glutamate
(1 mm) in a cell from the severe mutant line that showed no spontaneous synaptic events in more than 5 min of recording.
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currents was therefore likely to be due to lack of vesicular
release of neurotransmitter. Interpretation of this result,
however, was made difficult by many cultures of these
severe mutant cells having very low neuronal densities,
meaning that recorded cells were often isolated from
other neurons. Some of the quiescent neurons did have
near neuronal neighbours, and in two cases we patched on
to adjacent neurons to test synaptic activity directly by
stimulating each in turn: again we could not elicit post-
synaptic responses. Our results are thus consistent with
a deficit in synaptic vesicle release, although we cannot
completely rule out the apparent paucity of synaptic
events reflecting the sparsity of neuronal neighbours.
Discussion
We have succeeded in creating transmitochondrial
cybrids with mtDNA variations, on a mouse ES cell
nuclear background, which retain the ability to differentiate
into neurons. These cell lines maintained pluripotency,
as demonstrated by the presence of OCT-4 expression and
the ability of cells to undergo directed differentiation
into neurons. The cybrids represent a spectrum of severity
of compromised mitochondrial respiratory function. We
have generated a cybrid containing a polymorphism
that does not substantially affect function, two cybrids in
different ES cell backgrounds with the same mutation
in Mtco1, which causes a mild complex IV defect on
different ES cell backgrounds, and one cybrid with two
different mutations in Mtnd genes which cause a severe
complex I defect. Cybrids could be differentiated into
neurons, as evidenced by staining with neuron-specific
antibodies. Cell lines demonstrated electrophysiological
properties of mature neurons, action potentials and
synaptic potentials.
The most respiratory compromised cell line, CY3-I,
had the greatest deficiency in differentiation. Neuronal
development was severely reduced compared to the
parental ES cell line (ES-I) and with other cybrids
harbouring a mutation causing a milder biochemical
derangement (CY2-I and CY2-VI) or the polymorphism
which did not affect function (CY1-I). In contrast, CY3-I
produced less neurons. For CY2-I and CY2-VI, numbers
of neurons were similar to those produced by CY1-I and
the parental ES cells, and appearance of the cultures was
similar to each other and indistinguishable from those
derived from CY1-I and the parental cell lines. It had
less than 10% residual complex I activity and could only
generate approximately half the neurons of its ES cell
parent. Since the other cybrids exhibit no such compromise
of ability to generate neurons, it appears that the number
of neurons generated is related to the severity of the
biochemical defect and there is a relatively high threshold
for impairment (between 60% and 90%) for there to be
an effect.
Dependence of neuronal differentiation on complex I
function has been previously suggested by Papa et al.
(21). They showed a marked increase in complex I activity
during differentiation of mouse hippocampal cell cultures
into neurons and glia. The authors reported a significantly
higher complex I/complex III and complex I/complex IV
activity ratios in both isolated brain mitochondria and
in vitro differentiated hippocampal neurons than in other
mammalian tissues. Complex I activity appears to exhibit
strong control strength for respiratory chain activity, and
increase in complex I activity observed in these neural
tissues allows increase in energy metabolism to cope with
the energy demand required for differentiation. Thus, high
complex I activity appears to be required to maintain normal
neuronal activity by providing a high ATP production rate.
The severe complex I defect in CY3-I would presumably
result in insufficient respiratory chain activity and ATP
production, leading to the observed decreased differentiation
of ES cells into functional neurons.
The findings of Papa et al. (21) would support our
observation that decrease in neurons is due to decreased
proliferation during differentiation rather than increased
cell death, although contributions by both mechanisms
cannot be discounted. Complex I is a site of superoxide
production; therefore, free radical damage may also be
responsible for the paucity of neurons in CY3-I. In another
cybrid model of mtDNA disease affecting complex I,
Wong et al. (22) observed decrease in production of both
differentiated neurons and glial cells in LHON-NT2 cell
cybrids harbouring two of the most common LHON
mutations: 11778G>A and 3460G>A. They saw no difference
in morphology, expression of neuronal genes or mitochondrial
membrane potential between the parental NT2 cells and
the cybrids, but did find increased superoxide production in
differentiated neurons derived from the cybrids. Examination
of free radical production in our differentiated ES cell
cybrids may provide further clues to the mechanisms of
decreased neuronal differentiation. If increased reactive
oxygen species production is found to be a contributor,
this model provides the possibility of studying effects of
antioxidants and other treatments on neurons in vitro, and may
lead to translation into new and more effective treatments
for patients. Unlike this current study, however, Wong et al.
did not assess basic electrophysiological properties of
their apparently differentiated neurons (22).
We believe the strength of our approach is the relative
ease with which these electrophysiological studies can be
extended in this model of neuronal dysfunction caused by
mtDNA mutations. Here we have provided just a preliminary
description of the neuronal phenotypes, the most notable
feature being apparent deficit in synaptic function in cells
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with severely compromised mitochondrial activity. The
fact that these cells respond to exogenously applied
glutamate suggests that any deficit lies presynaptically,
consistent with other studies suggesting a role for mito-
chondria in synaptic release (23–29). Mitochondrial
dysfunction might affect synaptic function in a variety of
ways (reviewed in Ly and Verstreken (30)) both through
altered Ca2+ homeostasis within the presynaptic terminals
(26–29), or through deficits in ATP (24), since vesicle
cycling and refilling are both ATP-dependent (31). Our
preliminary explorations clearly do not distinguish between
these different possibilities, or the contribution of other
factors, such as a developmental delay or reduced neuronal
density. This cybrid technology will provide the means to
examine synaptic and other neuronal function in controlled
conditions of mitochondrial impairment, and test whether
different respiratory chain defects are equivalent in their
effect (32).
A potentially powerful alternative to our in vitro cell
culture studies is to model mtDNA defects in transgenic
mice, allowing neurophysiological analysis to be performed
on brain sections, slices or indeed primary neuronal
cultures. A recent publication from Fan et al. (5) has shown
that mouse oocytes harbouring mutated mtDNA that
underlies a severe respiratory phenotype selectively lose
this mtDNA rapidly during oogenesis, suggesting that the
production of a mouse model carrying a high mutant load
of a highly pathogenic mtDNA mutation may not be
possible. However, this was not the case for a mouse
generated with the same ‘mild’ missense mutation
(6589T>C in Mtco1) as two of our ES cell cybrids (33).
Mice homoplasmic for this mutation had decreased
cytochrome c oxidase (COX) staining in heart, decreased
COX activity in brain, heart, liver and skeletal muscle,
growth retardation and lactic acidosis. ES cell cybrids
have 50% residual complex IV activity, a similar level to
that observed in our cybrids carrying the same mutation.
Potentially these mice could provide a suitable model for
studying the effects of mild COX mutation on the brain.
However, residual COX activity in tissues tested in the
mice ranged between approximately 50% and 80%, with
brain close to 80%. This may not result in high enough
level of mitochondrial impairment to produce a neurological
phenotype. The authors noted that patients with MTCO1
and MTCO2 mutations had epilepsy or muscle weakness,
neither of which was observed in the mice. Our ES cybrids
had 40% residual COX activity, but it was not possible to
obtain enough differentiated neurons to perform respiratory
chain enzymology in them, so we do not know the level
of COX impairment in the differentiated neurons. The
differentiated neurons, however, behaved no differently
from those derived from the parental ES cells or the
cybrids harbouring the polymorphism. It is therefore likely
that this mutation is not severe enough to produce a deficit
that affects neuronal function, either in our in vitro system,
or in vivo in mice.
Accepting the difficulties in producing heteroplasmic
mice carrying severe pathogenic mtDNA mutations, it is
clear that differentiated neurons generated from ES cell-
derived cybrids provide an attractive model for human
mtDNA disease and for studying the effects of mtDNA
mutations on neuronal development and function. These
initial studies are promising and allow for longer-term
possibilities of determining the electrophysiological effects
of mtDNA mutations on neuronal subtypes, experiments
that are currently being pursued.
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